Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia: a Double-blind Randomized Controlled Trial

Trial Profile

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia: a Double-blind Randomized Controlled Trial

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 05 May 2017

At a glance

  • Drugs Amlodipine/folic-acid (Primary) ; Amlodipine
  • Indications Essential hypertension; Hyperhomocysteinaemia
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors Shenzhen Ausa Pharmed
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top